HESKA CORPORATION

HSKAUnited States

32 filed reports · 595 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$257M

FY2022 · to Dec 31, 2022

up +1.4% vs $254M

10-K

Net income

-$19.9M

FY2022 · to Dec 31, 2022

a year earlier: -$1.15M

10-K

Operating income

-$20.3M

FY2022 · to Dec 31, 2022

a year earlier: -$993K

10-K

Latest quarter

Revenue

$62.4M

Q1 FY2023 · to Mar 31, 2023

down −3.7% vs $64.8M

10-Q

Net income

-$10.1M

Q1 FY2023 · to Mar 31, 2023

a year earlier: -$9.99M

10-Q

Operating income

-$10.4M

Q1 FY2023 · to Mar 31, 2023

a year earlier: -$11.5M

10-Q

Filed reports

32 reports · Jun 2015 to Mar 2023

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR245,047Jun 2015 to Mar 2023
Annual · 10-KSEC EDGAR74,026Dec 2015 to Dec 2022
Annual · 10-K/ASEC EDGAR1465Dec 2017

Documents

PeriodTypePeriod endPublishedFactsSource
FY2023 Q110-Q2023-03-312023-05-05430Open
FY202210-K2022-12-312023-02-281,123Open
FY2022 Q310-Q2022-09-302022-11-08289Open
FY2022 Q210-Q2022-06-302022-08-08269Open
FY2022 Q110-Q2022-03-312022-05-09188Open
FY202110-K2021-12-312022-02-28569Open
FY2021 Q310-Q2021-09-302021-11-04210Open
FY2021 Q210-Q2021-06-302021-08-04195Open
FY2021 Q110-Q2021-03-312021-05-06220Open
FY202010-K2020-12-312021-02-26542Open
FY2020 Q310-Q2020-09-302020-11-05258Open
FY2020 Q210-Q2020-06-302020-08-07278Open

Financial data

595 concepts · 9,538 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial579 concepts · 8,336 facts · Dec 2013 to Mar 2023

  • Cash and cash equivalents at carrying value81 · Dec 2013 to Mar 2023
  • Cash cash equivalents restricted cash and restricted cash equivalents80 · Dec 2016 to Mar 2023
  • Comprehensive income net of tax47 · Dec 2013 to Mar 2023
  • Cost of revenue (US GAAP)47 · Dec 2013 to Mar 2023
  • Current income tax expense benefit47 · Dec 2013 to Mar 2023
  • Deferred income tax expense benefit47 · Dec 2013 to Mar 2023
  • General and administrative expense (US GAAP)47 · Dec 2013 to Mar 2023
  • Gross profit (US GAAP)47 · Dec 2013 to Mar 2023
  • Income loss from continuing operations before income taxes minority interest and income loss from equity method investments47 · Dec 2013 to Mar 2023
  • Income tax expense benefit47 · Dec 2013 to Mar 2023
  • Net income loss47 · Dec 2013 to Mar 2023
  • Operating expenses (US GAAP)47 · Dec 2013 to Mar 2023
  • Operating income loss47 · Dec 2013 to Mar 2023
  • Research and development expense47 · Dec 2013 to Mar 2023
  • Selling and marketing expense (US GAAP)47 · Dec 2013 to Mar 2023
  • Assets46 · Dec 2013 to Mar 2023
  • Depreciation and amortization46 · Dec 2013 to Mar 2023
  • Increase decrease in accounts payable trade45 · Dec 2013 to Mar 2023
  • Increase decrease in accounts receivable45 · Dec 2013 to Mar 2023
  • Increase decrease in inventories45 · Dec 2013 to Mar 2023
  • Interest expense (US GAAP)45 · Dec 2013 to Mar 2023
  • Net cash provided by used in financing activities45 · Dec 2013 to Mar 2023
  • Net cash provided by used in investing activities45 · Dec 2013 to Mar 2023
  • Net cash provided by used in operating activities45 · Dec 2013 to Mar 2023

Segment13 concepts · 843 facts · Dec 2013 to Mar 2023

  • Revenue357 · Dec 2013 to Mar 2023
  • Operating income loss99 · Dec 2013 to Mar 2023
  • Income loss from continuing operations before income taxes minority interest and income loss from equity method investments66 · Dec 2013 to Dec 2022
  • Depreciation and amortization65 · Dec 2013 to Dec 2022
  • Payments to acquire property plant and equipment56 · Dec 2013 to Mar 2020
  • Cost of revenue (US GAAP)44 · Dec 2018 to Mar 2023
  • Gross profit (US GAAP)44 · Dec 2018 to Mar 2023
  • Goodwill acquired during period26 · Dec 2019 to Mar 2023
  • Goodwill foreign currency translation gain loss26 · Dec 2019 to Mar 2023
  • Gross Margin, Percent22 · Jun 2019 to Mar 2023
  • Goodwill purchase accounting adjustments14 · Dec 2020 to Dec 2022
  • Gross Margin14 · Dec 2018 to Dec 2022
  • Capital expenditures incurred but not yet paid10 · Dec 2018 to Dec 2022

Product2 concepts · 256 facts · Dec 2016 to Mar 2020

  • Revenue253 · Dec 2016 to Mar 2020
  • Revenue from contract with customer including assessed tax3 · Mar 2018 to Sep 2018

Geography1 concept · 103 facts · Dec 2013 to Dec 2022

  • Revenue103 · Dec 2013 to Dec 2022

Segments

1,202 facts

Figures broken down by business line, region, product or another axis the company reports on.

Statement business segments5 members · 843 facts

  • International282 · Dec 2018 to Mar 2023
  • North America244 · Dec 2018 to Mar 2023
  • Other Vaccines, Pharmaceuticals and Products138 · Dec 2013 to Mar 2020
  • Core Companion Animal Health137 · Dec 2013 to Mar 2020
  • United States42 · Mar 2019 to Sep 2020

Product or servicesrt:ProductOrServiceAxis25 members · 245 facts

  • Outright instrument sales26 · Dec 2016 to Mar 2020
  • Core companion animal health17 · Dec 2016 to Mar 2020
  • Other vaccines, pharmaceuticals and products17 · Dec 2016 to Mar 2020
  • Contract Manufacturing Contracts16 · Dec 2016 to Mar 2020
  • Consumables13 · Dec 2016 to Mar 2020
  • License, research and development13 · Dec 2016 to Mar 2020
  • Other13 · Dec 2016 to Mar 2020
  • Other CCA revenue:13 · Dec 2016 to Mar 2020
  • Other pharmaceuticals, vaccines and diagnostic tests13 · Dec 2016 to Mar 2020
  • Point of Care imaging revenue:13 · Dec 2016 to Mar 2020
  • Point of Care laboratory revenue:13 · Dec 2016 to Mar 2020
  • Research and development, license and royalty revenue13 · Dec 2016 to Mar 2020
  • Sales-type leases13 · Dec 2016 to Mar 2020
  • Service revenue13 · Dec 2016 to Mar 2020
  • Operating type leases10 · Dec 2016 to Sep 2019
  • Laboratory Instruments3 · Mar 2018 to Sep 2018
  • Laboratory Supplies3 · Mar 2018 to Sep 2018
  • License and Royalty Income3 · Mar 2018 to Sep 2018
  • Operating Type Lease and Sales Type Lease3 · Mar 2018 to Sep 2018
  • Other Services3 · Mar 2018 to Sep 2018
  • Point of Care Imaging Products for Instruments and Software3 · Mar 2018 to Sep 2018
  • Rental Agreements3 · Mar 2018 to Sep 2018
  • Service Revenue3 · Mar 2018 to Sep 2018
  • Single-Use Diagnostic and Other Tests, Pharmaceuticals and Biologicals, Research and Development and Loyalty and Royalty Income3 · Mar 2018 to Sep 2018
  • Other License and Research and Development2 · Jun 2018 to Sep 2018

Statement geographicalus-gaap:StatementGeographicalAxis4 members · 53 facts

  • Other International15 · Dec 2013 to Dec 2017
  • Europe14 · Dec 2013 to Dec 2017
  • United States14 · Dec 2013 to Dec 2017
  • Canada10 · Dec 2014 to Dec 2017

Statement geographicalsrt:StatementGeographicalAxis9 members · 50 facts

  • Canada7 · Dec 2016 to Dec 2022
  • Other International7 · Dec 2016 to Dec 2022
  • United States7 · Dec 2016 to Dec 2022
  • France5 · Dec 2018 to Dec 2022
  • Germany5 · Dec 2018 to Dec 2022
  • Italy5 · Dec 2018 to Dec 2022
  • Spain5 · Dec 2018 to Dec 2022
  • Switzerland5 · Dec 2018 to Dec 2022
  • Europe4 · Dec 2016 to Dec 2019

Product or serviceus-gaap:ProductOrServiceAxis11 members · 11 facts

  • Contract Manufacturing Contracts1 · Mar 2018
  • Laboratory Instruments1 · Mar 2018
  • Laboratory Supplies1 · Mar 2018
  • License and Royalty Income1 · Mar 2018
  • Operating Type Lease and Sales Type Lease1 · Mar 2018
  • Other License and Research and Development1 · Mar 2018
  • Other Services1 · Mar 2018
  • Point of Care Imaging Products for Instruments and Software1 · Mar 2018
  • Rental Agreements1 · Mar 2018
  • Service Revenue1 · Mar 2018
  • Single-Use Diagnostic and Other Tests, Pharmaceuticals and Biologicals And Research and Development1 · Mar 2018

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of HESKA CORPORATION (HSKA) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.

HESKA CORPORATION (HSKA): FY2022 revenue $257M · FactIQ